CNE000001D56
CNE000001D56
CHINA NATIONAL MEDICINES CORP
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 20.12B EUR | 19.65B EUR | 22.11B EUR | 21.69B EUR |
Enterprise Value | 14.28B EUR | 12.05B EUR | 14.8B EUR | 10.73B EUR |
Valuation Multiples | ||||
Trailing P/E | 10.46x | 14.19x | 15.06x | 14.93x |
Forward P/E | 9.46x | -- | -- | -- |
Price to Sales | 0.38x | 0.49x | 0.56x | 0.56x |
Price to Book | 1.07x | 1.04x | 1.16x | 1.17x |
EV/Revenue | 0.27x | 0.3x | 0.37x | 0.28x |
EV/EBITDA | 6.69x | 6.28x | 7.47x | 5.47x |
Price to FCF (P/FCF) | 104.63x | 14.4x | 27.69x | 8.69x |
EV/FCF | 74.25x | 8.83x | 18.54x | 4.3x |
FCF Yield | 0.96% | 6.95% | 3.61% | 11.51% |